Post-earnings recap
Reported
Thu, Oct 25, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report indicates a slight miss on EPS, which may raise concerns among investors. However, the stock reacted positively, increasing by 0.45%. This could suggest that investors are still confident in the company's long-term growth potential despite the EPS miss.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.81 | N/A | -1.82% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism despite missing EPS expectations. They emphasized their commitment to innovation and market adaptation.
Management noted ongoing challenges in the market but expressed confidence in long-term growth.
They highlighted the importance of innovation in driving future sales.